Webinar: PCSS-MAUD Panel Discussion: Alcohol Use Disorder and Liver Transplantation–Ethical, Medical, and Social Perspectives

Date: Wednesday, May 21, 12:00 pm - 1:00 pm (EDT)

Moderator: Lamia Hague, MD, MPH
Panelists: Scott Winder, MD, MSc, Brian Lee, MD Juan Pablo Arab, MD, FRCPC, Jessica Mellinger, MD

Hosted By: the American Association for the Study of Liver Diseases (AASLD)

This webinar features a panel discussion to discuss the complex intersection of alcohol use disorder (AUD) and liver transplantation. This insightful conversation will explore the medical, ethical, and social challenges faced by healthcare professionals, patients, and policy makers in determining eligibility managing post-transplant care and addressing the stigma surrounding the issues.

AASLD is a PCSS-MAUD partner. Funding for this initiative was made possible by cooperative agreement no. 1H79TI086771-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Learning Objectives
Upon completion of this activity, participants should be able to:
• Describe the evidence behind current practices related to liver transplantation for patients with alcohol use disorder and alcohol-
associated liver disease.
• Review post-transplant outcomes in patients with alcohol use disorder and alcohol-associated liver disease.
• Identify approaches to providing alcohol use disorder treatment for patients with alcohol-associated liver disease across the pre- and post-
transplant continuum

Credit Offered
The American Association for the Study of Liver Diseases is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association for the Study of Liver Diseases designates this blended (live and enduring) activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.